A network analysis of angiogenesis/osteogenesis-related growth factors in bone tissue engineering based on in-vitro and in-vivo data: A systems biology approach

血管生成 生物 细胞生物学 再生(生物学) 组织工程 成纤维细胞生长因子 体内 生物化学 受体 癌症研究 生物技术 遗传学
作者
Nima Beheshtizadeh,Yazdan Asgari,Noushin Nasiri,Ali Farzin,Mohammad Ghorbani,Nasrin Lotfibakhshaiesh,Mahmoud Azami
出处
期刊:Tissue & Cell [Elsevier]
卷期号:72: 101553-101553 被引量:19
标识
DOI:10.1016/j.tice.2021.101553
摘要

The principal purpose of tissue engineering is to stimulate the injured or unhealthy tissues to revive their primary function through the simultaneous use of chemical agents, cells, and biocompatible materials. Still, choosing the appropriate protein as a growth factor (GF) for tissue engineering is vital to fabricate artificial tissues and accelerate the regeneration procedure. In this study, the angiogenesis and osteogenesis-related proteins' interactions are studied using their related network. Three major biological processes, including osteogenesis, angiogenesis, and angiogenesis regulation, were investigated by creating a protein-protein interaction (PPI) network (45 nodes and 237 edges) of bone regeneration efficient proteins. Furthermore, a gene ontology and a centrality analysis were performed to identify essential proteins within a network. The higher degree in this network leads to higher interactions between proteins and causes a considerable effect. The most highly connected proteins in the PPI network are the most remarkable for their employment. The results of this study showed that three significant proteins including prostaglandin endoperoxide synthase 2 (PTGS2), TEK receptor tyrosine kinase (TEK), and fibroblast growth factor 18 (FGF18) were involved simultaneously in osteogenesis, angiogenesis, and their positive regulatory. Regarding the available literature, the results of this study confirmed that PTGS2 and FGF18 could be used as a GF in bone tissue engineering (BTE) applications to promote angiogenesis and osteogenesis. Nevertheless, TEK was not used in BTE applications until now and should be considered in future works to be examined in-vitro and in-vivo.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
HS完成签到 ,获得积分10
1秒前
1秒前
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
4秒前
4秒前
4秒前
4秒前
4秒前
4秒前
4秒前
4秒前
热心小松鼠发布了新的文献求助100
4秒前
5秒前
5秒前
5秒前
5秒前
5秒前
5秒前
5秒前
5秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
The Three Stars Each: The Astrolabes and Related Texts 900
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
Bernd Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
A radiographic standard of reference for the growing knee 400
Glossary of Geology 400
Additive Manufacturing Design and Applications 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2473891
求助须知:如何正确求助?哪些是违规求助? 2138919
关于积分的说明 5451163
捐赠科研通 1862910
什么是DOI,文献DOI怎么找? 926240
版权声明 562817
科研通“疑难数据库(出版商)”最低求助积分说明 495483